{
  "trial_id": "NCT04000165",
  "overall_assessment": "likely_eligible",
  "inclusion": [],
  "exclusion": [
    {
      "criterion": "Documented pyruvate kinase deficiency",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Poorly controlled hypertension (defined as systolic blood pressure [BP] >150 mmHg or diastolic BP >90 mmHg) refractory to medical management.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "History of recent (within 6 months prior to signing informed consent) congestive heart failure; myocardial infarction or unstable angina pectoris; hemorrhagic, embolic, or thrombotic stroke; deep venous thrombosis; or pulmonary or arterial embolism.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Cardiac dysrhythmias judged as clinically significant by the Investigator.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Heart-rate corrected QT interval-Fredericia's method (QTcF) >480 msec with the exception of subjects with right or left bundle branch block.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Clinically symptomatic cholelithiasis or cholecystitis. Prior cholecystectomy is not exclusionary. Subjects with symptomatic cholelithiasis or cholecystitis may be rescreened once the disorder has been treated and clinical symptoms have resolved.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "History of drug-induced cholestatic hepatitis.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Iron overload sufficiently severe to result in a clinical diagnosis by the Investigator of cardiac (e.g., clinically significant impaired left ventricular ejection fraction), hepatic (e.g., fibrosis, cirrhosis), or pancreatic (e.g., diabetes) dysfunction.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Have a diagnosis of any other congenital or acquired blood disorder, or any other hemolytic process as defined by a positive direct antiglobulin test (DAT), except mild allo-immunization as a consequence of transfusion therapy.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Positive test for hepatitis B surface antigen or hepatitis C virus (HCV) antibody (Ab) with signs of active hepatitis B or C virus infection. If the subject is positive for HCV Ab, a reverse transcriptase-polymerase chain reaction test will be conducted. Subjects with hepatitis C may be rescreened after receiving appropriate hepatitis C treatment.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Positive test for human immunodeficiency virus 1 or 2 Ab.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a history of sickle cell disease and has had positive history of sickle cell crises since childhood. He also had the same symptoms in past two weeks treated with oxycodone which was not beneficial to his pain.",
  "_meta": {
    "topic_id": "45",
    "trial_id": "NCT04000165",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}